Additionally, CMTM6 knockdown could significantly reduce PD-L1 expression and increase infiltration of CD8+ and CD4+ T-cells, thereby enhancing the antitumor immunity in HNSCC [39]. The gene discussed is CD4; the disease is head and neck squamous cell carcinoma.